LT3210610T - Kompozicijos, turinčios triazonų ir geležies - Google Patents

Kompozicijos, turinčios triazonų ir geležies

Info

Publication number
LT3210610T
LT3210610T LTEP17160876.3T LT17160876T LT3210610T LT 3210610 T LT3210610 T LT 3210610T LT 17160876 T LT17160876 T LT 17160876T LT 3210610 T LT3210610 T LT 3210610T
Authority
LT
Lithuania
Prior art keywords
triazons
iron
compositions containing
compositions
containing triazons
Prior art date
Application number
LTEP17160876.3T
Other languages
English (en)
Inventor
Stefan Hofmann
Iris Heep
Hans-Christian Mundt
Juan Agustin Torres Islas
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39787877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3210610(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of LT3210610T publication Critical patent/LT3210610T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LTEP17160876.3T 2007-06-01 2008-05-21 Kompozicijos, turinčios triazonų ir geležies LT3210610T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007025908A DE102007025908A1 (de) 2007-06-01 2007-06-01 Formulierungen enthaltend Triazinone und Eisen

Publications (1)

Publication Number Publication Date
LT3210610T true LT3210610T (lt) 2020-05-25

Family

ID=39787877

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP17160876.3T LT3210610T (lt) 2007-06-01 2008-05-21 Kompozicijos, turinčios triazonų ir geležies

Country Status (27)

Country Link
EP (5) EP3741371A1 (lt)
JP (1) JP5591692B2 (lt)
KR (1) KR101517861B1 (lt)
CN (1) CN101678031B (lt)
AR (1) AR066780A1 (lt)
BR (2) BRPI0812172B8 (lt)
CL (1) CL2008001533A1 (lt)
CO (1) CO6241102A2 (lt)
CR (1) CR11121A (lt)
DE (1) DE102007025908A1 (lt)
DK (2) DK3711766T3 (lt)
ES (3) ES2789775T3 (lt)
FR (1) FR20C1049I1 (lt)
HR (2) HRP20170719T1 (lt)
HU (4) HUE049978T2 (lt)
LT (1) LT3210610T (lt)
MX (2) MX351332B (lt)
NI (1) NI200900206A (lt)
PE (1) PE20090757A1 (lt)
PL (3) PL3711766T3 (lt)
PT (3) PT2164496T (lt)
RU (1) RU2506081C9 (lt)
SI (2) SI3210610T1 (lt)
TW (1) TWI417101B (lt)
UA (1) UA97985C2 (lt)
UY (1) UY31106A1 (lt)
WO (1) WO2008145281A2 (lt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
SI22751A (sl) 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
KR101242535B1 (ko) * 2010-10-05 2013-03-12 주식회사이-글벳 콕시듐 치료 및 예방을 위한 조성물의 제조방법
CN102250261B (zh) * 2010-12-07 2013-02-20 天津怀仁制药有限公司 生产右旋糖酐铁的方法
CN102772363B (zh) * 2012-08-22 2013-10-09 青岛康地恩药业股份有限公司 一种含泊那珠利的溶液剂及其制备方法
EP2740470A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP2740469A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740492A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP3397278A1 (en) * 2015-12-29 2018-11-07 Intervet International B.V. Coccidiosis vaccine
KR102920596B1 (ko) 2018-05-16 2026-01-30 세바 상뜨 아니말르 수의학적 조성물 및 이의 비-인간 포유동물에서 철 결핍을 조절하기 위한 용도
EP3578182A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulations containing triazinones and iron with a low amount of free iron ions
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
CN109430556A (zh) * 2018-11-26 2019-03-08 江西新世纪民星动物保健品有限公司 一种包含托曲珠利和铁的制剂
WO2024138230A1 (en) * 2022-12-02 2024-06-27 Veterinary Pharmacy Corporation Formulation and method for treatment of infections

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1183940A (en) 1966-10-22 1970-03-11 Fisons Pharmaceuticals Ltd Ferric Hydroxide Complexes
DE2413722C3 (de) 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
DE3300793A1 (de) 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
JPH0776524A (ja) * 1993-07-13 1995-03-20 Takeda Chem Ind Ltd 動物用抗貧血剤
EP0634174A1 (en) 1993-07-13 1995-01-18 Takeda Chemical Industries, Ltd. Antianemic composition for veterinary use
DE19519821A1 (de) 1995-05-31 1996-12-05 Bayer Ag Mittel gegen parasitäre Protozoen
DE19603984A1 (de) 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
DE19824483A1 (de) * 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
HK1043019B (zh) 1998-10-08 2005-05-13 高新研究公司 用於预防和治疗原虫病的组合物和方法
HUP0104716A3 (en) * 1998-12-22 2003-10-28 Bayer Corp Pittsburgh Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing them
US6150361A (en) 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
US6194408B1 (en) * 1998-12-22 2001-02-27 Bayer Corporation Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma
DE19958388A1 (de) 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10049468A1 (de) 2000-10-06 2002-04-11 Bayer Ag N-Alkoxyalkyl-substituierte Benzimidazole, ihre Herstellung und ihre Verwendung als Mittel gegen parasitäre Protozoen
DE102004042958A1 (de) * 2004-09-02 2006-03-09 Bayer Healthcare Ag Neue antiparasitäre Kombination von Wirkstoffen
CN100453083C (zh) * 2005-11-19 2009-01-21 江西华太药业有限公司 右旋糖酐铁分散片
CN1839845A (zh) * 2006-01-24 2006-10-04 苏州科牧动物药品有限公司 含有妥曲珠利的抗球虫溶液及其制备方法
DE102006038292A1 (de) 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
EP2740469A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740470A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition

Also Published As

Publication number Publication date
EP3692993A1 (de) 2020-08-12
CA2688613A1 (en) 2008-12-04
SI2164496T1 (sl) 2017-06-30
KR101517861B1 (ko) 2015-05-18
EP3741371A1 (de) 2020-11-25
MX2009012406A (es) 2009-12-09
PL2164496T3 (pl) 2017-08-31
PL2164496T4 (pl) 2019-12-31
CR11121A (es) 2010-04-06
HRP20200777T1 (hr) 2020-07-24
JP5591692B2 (ja) 2014-09-17
UA97985C2 (ru) 2012-04-10
WO2008145281A8 (de) 2009-11-26
PT3711766T (pt) 2026-02-23
EP2164496B1 (de) 2017-04-12
ES2789775T3 (es) 2020-10-26
PT3210610T (pt) 2020-05-18
SI3210610T1 (sl) 2020-07-31
NI200900206A (es) 2011-08-10
PL3711766T3 (pl) 2026-05-11
RU2506081C2 (ru) 2014-02-10
DK3210610T3 (da) 2020-05-18
KR20110022510A (ko) 2011-03-07
HK1141993A1 (en) 2010-11-26
AR066780A1 (es) 2009-09-09
HUE031907T2 (en) 2017-08-28
RU2506081C9 (ru) 2014-09-27
DK3711766T3 (da) 2026-02-23
HUS2000041I1 (hu) 2020-11-30
BRPI0812172B1 (pt) 2020-03-03
BR122019020753B1 (pt) 2020-06-09
BRPI0812172B8 (pt) 2021-05-25
UY31106A1 (es) 2009-01-05
EP3210610A1 (de) 2017-08-30
CA2688613C (en) 2017-02-21
EP3711766A1 (de) 2020-09-23
JP2010528996A (ja) 2010-08-26
WO2008145281A2 (de) 2008-12-04
TWI417101B (zh) 2013-12-01
TW200914025A (en) 2009-04-01
EP3711766B1 (de) 2026-01-14
ES3062511T3 (en) 2026-04-13
CN101678031A (zh) 2010-03-24
EP3210610B1 (de) 2020-04-22
CN101678031B (zh) 2013-06-12
HUS1900046I1 (hu) 2019-11-28
WO2008145281A3 (de) 2009-08-13
BRPI0812172A2 (pt) 2014-12-02
BR122019020753B8 (pt) 2021-07-27
CO6241102A2 (es) 2011-01-20
HUE049978T2 (hu) 2020-11-30
MX336910B (es) 2016-02-02
DE102007025908A1 (de) 2008-12-04
MX351332B (es) 2017-10-11
EP2164496A2 (de) 2010-03-24
RU2009148585A (ru) 2011-07-20
PT2164496T (pt) 2017-05-22
PL3210610T3 (pl) 2020-07-27
HRP20170719T1 (hr) 2017-07-28
CL2008001533A1 (es) 2008-12-05
PE20090757A1 (es) 2009-07-23
ES2624794T3 (es) 2017-07-17
FR20C1049I1 (fr) 2020-11-27

Similar Documents

Publication Publication Date Title
LT3492069T (lt) Farmacinės kompozicijos, apimančios geležies oksihidroksidą
IL220009A0 (en) Indole compounds, compositions comprising the same and uses thereof
BRPI0810634A2 (pt) Composições fungicidas
HUE059171T2 (hu) Kompozíciók
BRPI0813775A2 (pt) Composição
DK2209856T3 (da) Aerogelsammensætninger
IL212836A0 (en) Azaquinolinone derivatives, compositions comprising the same and uses thereof
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
DK2245032T3 (da) Folater, sammensætninger og anvendelser deraf
IL212278A0 (en) Morpholinopurine derivatives, compositions comprising the same and uses thereof
BRPI0810557A2 (pt) composição
BRPI0811274A2 (pt) Composição
IL207372A0 (en) Phenylpyrrole derivatives, compositions comprising the same and uses thereof
BRPI0812172A2 (pt) Formulações contendo triazinonas e ferro
GB0706077D0 (en) Methods, Compositions and uses thereof
PT2182988E (pt) Composição radiofarmacêutica
BRPI0814748A2 (pt) Compostos de alditóis substituídos, composições e métodos
BRPI0811002A2 (pt) Composição biofertilizante
IL207639A0 (en) Pyrrolopyrimidinecarboxamide compounds, compositions comprising the same and uses thereof
BRPI0807920A2 (pt) Composições epilatórias
BRPI0820960A2 (pt) composição
BRPI0807903A2 (pt) Composições medicinais melhoradas compreendendo buprenorfina e nalmefeno.
FI20075086L (fi) Aromikoostumus
GB0715068D0 (en) Improved composition
EP2119430A4 (en) PERLENDE COMPOSITION